Skip to main content
. 2017 Jan 5;13(3):1223–1227. doi: 10.3892/ol.2017.5573

Figure 2.

Figure 2.

Patients with higher expression levels of DRD2 exhibit shorter survival durations. (A) Correlation between the expression levels of DRD2 and the survival durations of patients with gastric cancer, analyzed using the Kaplan-Meier method. (B) Analysis of the correlation between the survival durations of patients with gastric cancer and the expression levels of DRD2 was performed using the Kaplan-Meier method and online resources. DRD2, dopamine receptor D2.